Recognizing and Treating Ocular Rosacea in Darker Skin Tones - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Recognizing and Treating Ocular Rosacea in Darker Skin Tones

IPL, laser, and LLLT should be chosen carefully for safety across the spectrum of skin tones.

  • By

  • Sarah Fackler, managing editor, Optometric Management

  • January 1, 2026

  • 4 min

Share

Clinical Scorecard: Recognizing and Treating Ocular Rosacea in Darker Skin Tones

At a Glance

CategoryDetail
ConditionOcular Rosacea
Key MechanismsSubtle presentation in darker skin tones, with potential for postinflammatory hyperpigmentation and meibomian gland dysfunction.
Target PopulationPatients with darker skin tones (Fitzpatrick classifications IV to VI).
Care SettingClinical settings providing dermatological and ophthalmological care.

Key Highlights

  • Ocular rosacea is common in dark-skinned females and presents differently than in lighter skin tones.
  • Treatment options include IPL, laser, and LLLT, with careful parameter selection for skin type.
  • Combination of IPL and meibomian gland expression yields superior results.
  • Post-treatment care is crucial to prevent hyperpigmentation and manage adverse events.
  • Education and training for staff are essential for effective treatment integration.

Guideline-Based Recommendations

Diagnosis

  • Recognize subtle signs of ocular rosacea in darker skin tones, including eyelid telangiectasia.

Management

  • Utilize IPL with conservative settings for treatment, especially in resistant cases.

Monitoring & Follow-up

  • Document all adverse events and adjust treatment protocols accordingly.

Risks

  • Monitor for hyperpigmentation and manage with topical agents if necessary.

Patient & Prescribing Data

Patients with ocular rosacea, particularly those with darker skin tones.

Standardized forms should be used to determine Fitzpatrick skin type for appropriate treatment parameters.

Clinical Best Practices

  • Implement a waiting period of 4 weeks between initial IPL treatments.
  • Ensure comprehensive patient education materials reflect diverse skin tones.
  • Maintain a comfortable treatment environment with necessary supplies.

Related Resources & Content

Original Source(s)

Recognizing and Treating Ocular Rosacea in Darker Skin Tones

  • by Sarah Fackler, managing editor, Optometric Management

  • January 1, 2026

Related Content

Dry Eye After Cataract Surgery

Scientific Reports study compares dry eye effects of phacoemulsification and MSICS

  • February 16, 2026

  • 3 min
Biocompatibility and Contact Lens Wear

In this feature, Alex Hui, OD, PhD, looks at the research and determines that contact lenses could be considered one of the most successful examples of biocompatible devices used. He further examines contact lens dropout and how to achieve contact lens wear success.

Dry Eye Updates Highlight Diagnostic Precision and Tailored Care

“As optometrists, our responsibility is not only to recognize dry eye disease early but also to match the right treatment to the right patient,” said Dr. Kalfayan.